Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Tachyon Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Tachyon Ventures

Tachyon Ventures

Operating

Tachyon Ventures: Investing in early-stage life sciences, medicine, biotech, and bioengineering.

Location
Los Angeles, CA, US
Founded
2017
Firm
Compare
Portfolio
Employees
Website

Tachyon Ventures focuses on early-stage investments in the life sciences sector, particularly in medicine, biotech, and bioengineering. The firm typically participates in Seed, Series A, and Series B rounds, providing smart capital to entrepreneurs pushing the boundaries of scientific innovation. Their investment strategy is centered around supporting ventures at the forefront of medical and biotechnological advancements.

Notable portfolio companies include Mammoth Biosciences, EnClear Therapies, and Scipher Medicine. Tachyon Ventures prides itself on its network of deeply knowledgeable scientists from world-leading research institutions. This network allows them to offer unique value-add services, including expert guidance and strategic support to their portfolio companies. The firm's investment philosophy is rooted in leveraging scientific expertise to drive transformative advancements in the life sciences industry.

Tachyon Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments11
Current Portfolio Count8
Total Portfolio Exits0

Top Investment Stages

Seed4 (40.0%)
Series A2 (20.0%)
Series B2 (20.0%)
Series C1 (10.0%)
Series D1 (10.0%)

Stage Mix

Seed 40%Series A 20%Series B 20%Series C 10%Series D 10%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Altay Therapeutics logo

Altay Therapeutics

Mammoth Biosciences logo

Mammoth Biosciences

Chameleon Biosciences logo

Chameleon Biosciences

Scipher Medicine logo

Scipher Medicine

EnClear Therapies logo

EnClear Therapies

Peptilogics logo

Peptilogics

Forkhead BioTherapeutics logo

Forkhead BioTherapeutics

Epi One logo

Epi One

Tachyon Ventures - Similar Investment Firms

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

Nest.Bio Venture logo

Nest.Bio Venture

nest.bio

Bioventures Investors logo

Bioventures Investors

Targeted Technology Fund logo

Targeted Technology Fund

targetedtech.com

Versant Ventures logo

Versant Ventures

Vye Ventures logo

Vye Ventures

SeedFolio logo

SeedFolio

Chamaeleon logo

Chamaeleon

chamaeleon.vc

Tunitas Ventures logo

Tunitas Ventures

Flywheel Ventures logo

Flywheel Ventures

Engage Venture Partners logo

Engage Venture Partners

engagevp.com

Time Bioventures logo

Time Bioventures

Inctank Ventures logo

Inctank Ventures

inctank.com

Breakout Ventures logo

Breakout Ventures

breakout.vc

Tachyon Ventures - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end